Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY)

CAPS Rating: 4 out of 5

A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.

Recs

0
Player Avatar istraveler (< 20) Submitted: 12/29/2010 1:37:53 AM : Outperform Start Price: $34.24 RDY Score: -14.15

generic drugs + 7 Billion worldwide population = mega trend upside potential.

Featured Broker Partners


Advertisement